The company's core activity is the development, manufacture and marketing of pharmaceuticals, biotechnology products, active pharmaceutical ingredients (APIs) and specialized hospital services. The company focuses on research and development of new medicines, particularly antibiotics, and offers a wide range of dosage forms, including tablets, capsules, injection solutions and vaccines. It is also active in contract manufacturing of APIs and the production of specialized medicines.